It is designed for rare disease trials where patient populations are often small and geographically dispersed, making multinational collaboration essential
Acknowledgements The CorEvitas Psoriasis Registry was developed in collaboration with the National Psoriasis Foundation (NPF)
Here, B12 shots are given once a month
Injectable BPC-157 is administered subcutaneously or intramuscularly, completely bypassing the digestive system
BPC 157, also known as PLD-116, PL-10, PL14736 [9], or Bepectin [10,11,12,13,14,15,16,17], has recently attracted considerable attention as a potential drug candidate that is stable in acidic environments and has no serious adverse effects [18], although it has been known to cause pain and/or necrosis when injected in an aqueous solution or in physiological saline [19]